Common use of Study and Site Closure Clause in Contracts

Study and Site Closure. ‌‌‌ The Sponsor designee reserves the right to close the study site or terminate the study at any time for any reason at the sole discretion of the Sponsor. Study sites will be closed upon study completion. A study site is considered closed when all required documents and study supplies have been collected, and a study-site closure visit has been performed. The Investigator may initiate study-site closure at any time, provided there is reasonable cause and sufficient notice is given in advance of the intended termination. Reasons for the early closure of a study site by the Sponsor or Investigator may include but are not limited to: • Failure of the Investigator to comply with the protocol, the requirements of the IRB/IEC/REB or local health authorities, the Sponsor’s procedures, or GCP guidelines • Inadequate recruitment of subjects by the Investigator • Discontinuation of further study drug development

Study and Site Closure. ‌‌‌ The Sponsor or designee reserves the right to close the study site or terminate the study at any time for any reason at the its sole discretion of the Sponsordiscretion. Study sites will be closed upon study completion. A study site is considered closed when all required documents and study supplies have been collected, collected and a study-study site closure visit has been performed. The Investigator investigator may initiate study-study site closure at any time, provided there is reasonable cause and sufficient notice is given in advance of the intended termination. Reasons for the early closure of a study site by the Sponsor or Investigator investigator may include but are not limited to: • Failure of the Investigator investigator to comply with the protocol, the requirements of the IRB/IEC/REB IEC or local health authorities, the Sponsor’s 's procedures, or GCP guidelines • Inadequate recruitment of subjects by the Investigator investigator • Discontinuation of further study drug treatment development.

Study and Site Closure. ‌‌‌ ‌ The Sponsor or designee reserves the right to close the study site or terminate the study at any time for any reason at the sole discretion of the Sponsor. Study sites will be closed upon study completion. A study site is considered closed when all required documents and study supplies have been collected, collected and a study-site closure visit has been performed. The Investigator may initiate study-site closure at any time, provided there is reasonable cause and sufficient notice is given in advance of the intended termination. Reasons for the early closure of a study site by the Sponsor or Investigator may include but are not limited to: • Failure of the Investigator to comply with the protocol, the requirements of the IRB/IEC/REB IEC or local health authorities, the Sponsor’s 's procedures, or GCP guidelines • Inadequate recruitment of subjects patients by the Investigator • Discontinuation of further study drug treatment development